Anti-Terrorism Act Case Could Bring New Risks For US Cos.

By Douglas Hallward-Driemeier, Jonathan Ference-Burke and Caroline Boisvert (June 21, 2019, 2:23 PM EDT) -- Atchley v. AstraZeneca UK Ltd.,[1] an Anti-Terrorism Act lawsuit filed in the U.S. District Court for the District of Columbia, poses groundbreaking questions regarding whether a U.S.-based corporation can be held liable for terrorist acts based on a tenuous causal relationship derived from commercial transactions with a foreign government.

There is little existing law under the ATA, and Atchley seeks to expand liability under the statute in a manner that may have significant implications for how corporations conduct business abroad. As such, Atchley represents a potential new frontier of lawsuits in the mold of Alien Tort Statute cases like Jesner v....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!